MAGGIE WINTER: Open Payments
NPI 1053691899 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 29 payments from 15 companies in 2025. Trend: 2023 $457 · 2024 $491 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Esperion Therapeutics, Inc. | 4 | $70 |
| Lilly USA, LLC | 3 | $53 |
| Amgen Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $41 |
| ABBVIE INC. | 2 | $41 |
| Exact Sciences Corporation | 2 | $32 |
| Corcept Therapeutics | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: NEXLETOL, MOUNJARO, AIRSUPRA, Cologuard Collection Kit, FARXIGA, Rybelsus, QULIPTA, Korlym.
Industry payments across NY — which companies pay providers there.
